Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2003-10-17
2008-12-09
Tsang, Cecilia J (Department: 1654)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C514S002600
Reexamination Certificate
active
07462365
ABSTRACT:
This invention relates to compositions for the sustained release of biologically active polypeptides, and methods of forming and using said compositions, for the sustained release of biologically active polypeptides. The sustained release compositions of this invention comprise a biocompatible polymer having dispersed therein, a biologically active polypeptide, a sugar and a salting-out salt.
REFERENCES:
patent: 3523906 (1970-08-01), Claeys et al.
patent: 3691090 (1972-09-01), Kitajima et al.
patent: 3737337 (1973-06-01), Schnoring et al.
patent: 3891570 (1975-06-01), Fukushima et al.
patent: 3960757 (1976-06-01), Morishita et al.
patent: 4389330 (1983-06-01), Tice et al.
patent: 4530840 (1985-07-01), Tice et al.
patent: 5019400 (1991-05-01), Gombotz et al.
patent: 5126147 (1992-06-01), Silvestri et al.
patent: 5225205 (1993-07-01), Orsolini
patent: 5336505 (1994-08-01), Ng et al.
patent: 5385887 (1995-01-01), Yim et al.
patent: 5424286 (1995-06-01), Eng
patent: 5578567 (1996-11-01), Cardinaux et al.
patent: 5589167 (1996-12-01), Cleland et al.
patent: 5656297 (1997-08-01), Bernstein et al.
patent: 5672659 (1997-09-01), Shalaby et al.
patent: 5834428 (1998-11-01), Drucker
patent: 5922253 (1999-07-01), Herbert et al.
patent: 5981719 (1999-11-01), Woiszwillo et al.
patent: 6113947 (2000-09-01), Cleland et al.
patent: 6190702 (2001-02-01), Takada et al.
patent: 6369116 (2002-04-01), Wong et al.
patent: 6465425 (2002-10-01), Tracy et al.
patent: 6506724 (2003-01-01), Hiles et al.
patent: 6749866 (2004-06-01), Bernstein et al.
patent: 2004/0028733 (2004-02-01), Tracey et al.
patent: 2004/0047863 (2004-03-01), Bendele et al.
patent: 2007/0027085 (2007-02-01), Costantino et al.
Edwards et al. Exendin-4 reduced fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am. J. Physiol. Endocrinol. Metab., Jul. 2001, vol. 281: pp. E155-E161.
Elvassore, Nicola et al., Production of Insulin-Loaded Poly(Ethylene Glycol)/Poly(I-Lactide) (PEG/PLA) Nanoparticles by Gas Antisolvent Techniques, J. of Pharmaceutical Sci., 90(10):1628 (Oct. 2001).
Lee and Timesheff, The Stabilization of Proteins by Sucrose, J. Biological Chem, 256(14):7193-7201 (1981).
Taylor, K. et al., Continuous Subcutaneous Infusion of AC2993 (Synthetic Exendin-4) Provides Sustained Day-Long Glycemic Control to Patients with Type 2 Diabetes (51(Suppl 2):A85 (Jun. 2002 Conference Abstract).
Haynes, Lia M. et al. “Neutralizing Anti-F Glycoprotein and Anti-Substance P Anitbody Treatment Effectively Reduces Infection and Inflammation Associated with Respiratory Syncytial Virus Infection.”Journal of Virology. 76. 14 (2002): 6873-6881.
Kurt-Jones, Evelyn A. et al. “Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus”.Nature Immunology. 1.5 (2000): 398-401.
U.S Appl. No. 10/688,786, file Oct. 17, 2003, Costantino et al.
Creighton, Thomas E.,In “Proteins: Structures and Molecular Principles,” Punlished by W.H. Freeman and Company, NY) pp. 149-150.
Lucke, et al. Peptide Acylation by Poly(a-Hydroxy Esters), Pharmaceutical Research, 19(2):175-181 (2002).
Bobka Edward W.
Costantino Henry R.
Hotz Joyce M.
Cordero Garcia Marcela M
Covington & Burling LLP
Reister Andrea G.
Tsang Cecilia J
LandOfFree
Microencapsulation and sustained release of biologically... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Microencapsulation and sustained release of biologically..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Microencapsulation and sustained release of biologically... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4026769